We recently established transgenic animals (WAP-SV-T/ t) carrying the early coding region of Simian Virus 40 (SV40) under the transcriptional control of the whey acidic milk protein promoter (WAP), which restricts the expression of the transgene to mammary gland epithelial cells (ME-cells). SV40 T/t-antigen synthesis causes premature mammary gland involution during late pregnancy by inducing apoptosis and leads to development of mammary tumors after the ®rst lactation period in both p53 positive (WAP-SV-T/t) and p53 negative double transgenic animals (WAP-SV-T/t.p537/7). The high apoptotic rate persists in all of the T/t-antigen positive breast tumor cells, as well as in established MEtissue culture cell lines. ME-cells which spontaneously switch o the expression of the WAP-SV-T/t transgene do not undergo apoptosis. However, these cells again exhibit an extensive DNA fragmentation when SV40 T/ t-antigen synthesis is reintroduced, which indicates that it is the expression of T/t antigen which is the critical factor for induction of apoptosis. In addition, we isolated several ME-cell lines from dierent breast tumors which have spontaneously lost the T/t-antigen yet remain maximally transformed. Strikingly, these cells contain a missense mutation of the p53 gene at codon 242 (p53 242 ), which substitutes alanine for glycine. This mutation increases p53 stability and it reduces the transactivating function of p53, albeit without aecting the ability of the protein to interact with the DNA. This indicates that p53 missense mutations are selected for in breast tumors initially expressing T/t-antigen. Therefore, the p53 242 mutation is sucient to maintain the transformed state after the ME-cells have switched o the WAP-SV-T/t transgene. Interestingly, the p53 minus state per se is not sucient to induce ME-cell transformation since homozygous null mice for the p53 gene (p537/7) fail to develop breast cancer.
Introduction
Balanced coordination between proliferation and programmed cell death (apoptosis) is a fundamental feature of organ dierentiation and is essential for maintaining homeostasis in the dierentiated state. An increased rate of cell death can impair development and cause degenerative diseases, whereas a reduced apoptotic rate may lead to cancer. Apoptosis is regulated at dierent levels, including cell-cell communication, cell-matrix interaction and also in isolated cells through activation of intrinsic programmed death without a distinct external stimuli (reviewed in White, 1996) .
It is evident that there are multiple genes involved which either induce or prevent cell death in a given cell type and in a dierentiation-dependent fashion. One protein which plays a key role in cell transformation and apoptosis is the p53 tumor repressor gene product. When overexpressed, p53 can either induce cell cycle arrest or apoptosis (reviewed in Levine, 1997 ). The precise role of p53 in apoptosis is still not certain but it has been shown to activate death genes (e.g. bax) or repress transcription of survival genes (e.g. bcl-2). The activity of p53 is further aected by numerous viral proteins such as the SV40 T-antigen which creates a pseudo p53 null state. Sequestration of p53 is considered critical for the oncogenic and the antiapoptotic function of T-antigen (Zheng et al., 1994; McCarthy et al., 1994; Guenal and Mignotte, 1995; Lenahan and Ozer, 1996; Conzen et al., 1997) .
One organ that periodically undergoes, extensive cell proliferation and dierentiation, followed by organ regression, is the mammary gland. The dominant cell type in the glands of virgin animals are adipose cells. With each pregnancy these cells are replaced by highly dierentiated mammary epithelial cells (ME-cells) which form the alveolar and ductal structures that monopolize the gland during the lactation period (Daniel and Silberstein, 1987) . Mammary gland development and milk protein synthesis (e.g. whey acidic protein) are under the control of various lactotrophic hormones (e.g. estrogen, progesterone, prolactin, insulin, glucocorticoids) and local growth factors (Topper and Freeman, 1980; Hobbs et al., 1982; Daniel and Silberstein, 1987) . During these lactation periods it is of importance that the ME-cells be protected against apoptosis to maintain the integrity of the organ and to feed the newborn. However, shortly after weaning, the milk genes are switched o and the epithelial cells are again replaced by adipose cells. Through this programmed cell death the major part of the mammary tissue is removed within a few days, accounting for about 20% of the entire body weight of the animals. So far it is not certain which gene products prevent apoptosis during pregnancy and lactation and which induce apoptosis when the suckling stimulus ceases after weaning. This balanced cooperation between dierentiation and apoptosis involves both p53-dependent and p53-independent pathways but p53 per se is not absolutely essential since p537/7 animals have almost normal mammary gland development (McCarthy et al., 1994; Merlo et al., 1995; Shibata et al., 1996) .
We recently generated transgenic animals which carry the early SV40 coding region (T/t-antigen) under the transcriptional control of the whey acidic milk protein promoter (WAP-SV-T/t). Transcription of the WAP-SV-T/t transgene is restricted to the ME-cells and is co-regulated with WAP gene expression during pregnancy and the lactation period. As one consequence of the T/t-antigen synthesis all females have a reduced lactation capacity and the ospring have to be nursed by foster mothers (Tzeng et al., 1993) . The reason for this`milk-less' phenomenon is a premature mammary gland involution, which occurs during late pregnancy when about 70 ± 80% of the mammary glands epithelial cells are eliminated by apoptosis (Tzeng et al., 1996) . However, after lactation the mammary glands still contain multiple SV40 T-antigen positive cell islands which in time expand and develop into breast tumors after the ®rst lactation period (Santarelli et al., 1995) . This may indicate that in these cells T/t-antigen exerts an anti-apoptotic rather than an apoptotic activity which promotes tumor formation.
To test this possibility, we analysed programmed cell death in breast tumor cells and in ME-tissue culture cell lines. These experiments revealed that all T/tantigen positive ME-cells exhibit a spontaneous apoptosis rate as high as that of the ME-cells at late pregnancy. Furthermore, two categories of T/t-antigen negative ME-cell lines were established which do not exhibit a spontaneous DNA fragmentation pattern. Cells of the ®rst type have the morphology and growth characteristic of normal ME-cells, while cells of the second category are highly tumorigenic. The latter cells are selected for a missense mutation at the second base of the codon 242 (p53 242 ), which is part of the DNA binding domain IV of p53 (Cho et al., 1994) . The p53 242 has an enhanced stability; it retains the DNA binding speci®city of the wild-type p53 but has a reduced transactivation activity. In addition, the missense mutation confers resistance on cells to apoptosisinducing agents such as doxorubicin and U.V. irradiation.
Results

SV40 T/t-antigen induces premature mammary gland involution by apoptosis in a p53 independent fashion
In transgenic mice (strain: NMRI) of the line eight expression of the WAP-SV-T/t transgene occurs in the mammary gland epithelial cells (ME-cells) in synchrony with the endogenous WAP gene. SV40 T/t-antigen synthesis has no signi®cant eect during early pregnancy but replacement of the adipose cells by the ME-cells occurs faster than in the glands of normal animals (Santarelli et al., 1995) . However, around day 18 of pregnancy all WAP-SV-T/t animals exhibit a premature mammary gland involution, which eliminates the majority of the epithelial cells. As a consequence the animals are`milk-less'. Apoptotic cell death is indicated by distinct morphological alterations such as nuclear condensation and shedding of the cells into the alveolar and ductal lumen; it is further demonstrable by TUNEL or Hoechst dye 33258 staining (Tzeng et al., 1996) and spontaneous DNA fragmentation which continues until the third day of the lactation period (Figure 1c ). At day 3 ± 4 of lactation, the morphology of the glands resembles that of virgin animals. In non-transgenic animals mammary gland involution occurs in a similar fashion but only after weaning (Figure 1a) . However, immuno¯uorescence staining experiments have revealed that not all SV40 T/t-antigen positive ME-cells are eliminated by apoptosis (Santarelli et al., 1995) . To test whether in these cells the SV40 T/t-antigen has an antiapoptotic eect, small gland tissue segments were isolated shortly after lactation and at dierent stages during tumor progression and DNA fragmentation was analysed. As exemplarily shown for the tumor 8/61, these cells exhibited a high spontaneous DNA fragmentation pattern at a rate similar to that observed in ME-cells at late pregnancy (Figure 1d ). Therefore, these results exclude an anti-apoptotic function of the T-antigen in these cells.
To evaluate whether the p537/7 state might aect the extent of premature apoptosis or breast tumor formation, the WAP-SV-T/t animals were paired with p537/7 animals (the p537/7 animals were kindly provided by G Brandner). We observed that both the WAP-SV-T/t.p53+/7 and the WAP-SV-T/t.p537/7 animals have a premature mammary gland involution during late pregnancy similar to that of the WAP-SV-T/t animals. As illustrated in Figure 1b , DNA fragmentation also occurs at day 18 of pregnancy and all females are`milk-less'. Furthermore, the p53 null state does not increase the risk of breast cancer since none of the p537/7 animals developed spontaneous breast tumors and in the case of the double-transgenic WAP-SV-T/t.p53+/7 and WAP-SV-T/t.p537/7 animals breast cancer formation is not accelerated (data not shown).
SV40 T/t-antigen positive ME tissue culture cells lines exhibit a high spontaneous apoptosis rate
To determine whether the high spontaneous apoptotic rate is restricted to ME-cells of solid tumors, tissue segments were isolated from mammary glands during pregnancy and from several tumors (e.g. tumor 8/61). In order to establish tissue culture cell lines, small tissue segments were plated on culture dishes without additional enzymatic treatment and further cultivated under standard conditions (DMEM, 10% FCS). When mammary gland tissue segments from normal mice were plated, some ME-cell grew out from the explant (Figure 2a ) but they had a limited life span. With time the ME-cells were overgrown by ®broblasts and after the second trypsinization the ®broblasts were the dominant cell type (Figure 2b ). In contrast, after plating of mammary gland or breast tumor tissue segments from the WAP-SV-T/t animals, ME-cells grow out eciently from tissue segments, giving rise to stable ME cell lines (Figure 2c ). In this way numerous stable SV40 T/t-antigen positive ME-cells lines were established, as is exemplarily shown for the 8/61A cells (Figure 3a) . The 8/61A cells were obtained from the tumor 8/61 and are immortalized ME-cells (passage number 4200) which grow with a high eciency in soft agar ( Figure 4b ) and form tumors after injection into NMRI mice. These cells express the WAP-SV-T/t transgene with a high eciency as shown by Northern blot analysis ( Figure 5 ), Western blot analysis ( Figure 6 ) and immuno¯uorescence staining while expression of the endogenous WAP gene is only demonstrable by RT ± PCR analysis ( Figure 7 ). As shown in Figure 1d , the 8/61A cells still exhibit a high spontaneous DNA fragmentation pattern as high as that of the ME-cells at late pregnancy. TUNEL and propidium iodide staining revealed that about 12 ± 15% of the 8/61A cells are apoptotic (Table 1) . To test whether these apoptotic cells represent a subpopulation, the 8/61A cells were twice re-cloned in soft agar and found to have the same high spontaneous apoptotic rate as the primary isolates.
SV40 T/t-antigen negative ME-cells have a low apoptotic rate
T-antigen staining further revealed that about 20 ± 30% of the breast tumors also contain T-antigen negative ME-cells. Furthermore, ME-cells frequently switch o both the endogenous WAP and the WAP-SV-T/t transgene soon after the transfer into tissue culture (passage 1 ± 3) as is exemplarily shown for the 8/61B cells ( Figure 3c ). As were the 8/61A cells, the 8/61B cells were also obtained from the tumor 8/61. Expression of both the endogenous WAP and the WAP-SV-T/t transgene is neither demonstrable by Northern blot ( inoculation into NMRI mice. So far we have no explanation of why both the WAP and the WAP-SV-T/t transgenes are switched o in the 8/61B cells, while the 8/61A cells down-regulate only the WAP gene expression. Down-regulation is not associated with an alteration in the steroid hormone receptor level since the T-antigen positive and the T-antigen negative MEcells have a similar progesterone-, estrogen-and glucocorticoid-receptor level (data not shown). However, addition of lactotrophic hormones (e.g. estrogen, progesterone, prolactin, insulin, glucocorticoids) to the culture medium caused neither WAP nor WAP-SV-T/t gene activation. Further, alteration of the DNA methylation pattern seems not to account for WAP and WAP-SV-T/t gene inactivation, since restriction enzyme and Southern blot analysis revealed that the WAP-promoter of both genes is still demethylated in the 8/61A and 8/61B cells (data not shown). In contrast to the T/t-antigen positive ME-cells the 8/ 61B cells do not exhibit a spontaneous DNA fragmentation pattern ( Figure 1d ) and only 1 ± 3% of them are positive on TUNEL or propidium iodide staining (Table 1 ). Since the Bax mRNA level increases in cells during mammary gland involution after lactation (Heermeier et al., 1996; Merlo et al., 1997) , the Bax expression rate was analysed in the 8/61A and 8/61B cells by RT ± PCR analysis but there was no signi®cant dierence between the high and low apoptotic cells (Figure 7) . To determine the expression rate of the Bcl-X gene, primers were utilized for RT ± PCR ampli®cation which allow identi®cation of the two splice variants, the anti-apoptotic Bcl-xL and the apoptotic Bcl-xS form. As shown in Figure 7 generation of the Bcl-xS splice form was not demonstrable by RT ± PCR and the Bcl-xL mRNA was dominant. As with Fas, the level of TNF-R and the c-myc expression rate was similar in all ME-cell types (Figure 7) .
To con®rm that it is the T/t-antigen that mediates spontaneous cell death, wild-type SV40 DNA was transfected together with the pSVneo DNA into the 8/ 61B cells and T/t-antigen positive cell clones were selected (8/61B-T/t cells). To test apoptosis cellular DNA was extracted from 8/61B-T/t cells and subjected to agarose gel electrophoresis. As shown in Figure 1d , T/t-antigen synthesis again caused DNA fragmentation and cell death (Table 1) .
A p53 missense mutation (codon 242) is selected for in breast tumors
We further obtained several SV40 T/t-antigen negative cell lines from the 8/61 tumor which remain highly tumorigenic (e.g. 8/61C). As shown in Figure 1d the 8/ 61C cells do not exhibit a spontaneous DNA fragmentation pattern and only 1 ± 3% exhibit a TUNEL and propidium iodide reaction (Table 1) . However, after transfection of SV40 DNA the 8/61C cells (8/61C-T/t) displayed a similar apoptotic rate as the 8/61A cells (data not shown). The 8/61C cells have the morphology and growth characteristic of tumor cells (Figure 4e ), they grow with a high eciency in In contrast to the non-tumorigenic 8/61B cells, the 8/61C cells exhibited a permanent intranuclear p53 staining (Figure 3f) and the elevated p53 level was further con®rmed by Western blotting (Figure 6 ). To test whether an increased p53 expression rate accounts for the high level of p53, total RNA was extracted from the three ME-cell types (8/61A, B, C cells) and subjected to Northern blot analysis. As shown in Figure 5 all cell types have comparable amounts of p53 mRNA. Similar results were obtained when the cDNAs were subjected to PCR analysis (Figure 7) . This indicates that all three cell lines have the same p53 transcription rate and that an increased stability must account for the elevated p53 level in the 8/61C cells.
To further characterize the p53 gene in the 8/61C cells, the 8/61C cDNA was subjected to PCR ampli®cation. Using dierent sets of primers, the entire p53 coding region was ampli®ed and the PCR products were directly sequenced without further cloning. These experiments revealed that the p53 gene of the 8/61C cells carries a missense mutation at codon 242 (p53 242 ). The second base of this codon is converted from G to C (GGC to GCC) encoding now for alanine instead of glycine ( Figure 9a) . As has been shown elsewhere, the codon 242 is located at the seventh exon of the p53 and is part of the conserved region IV, which is required for speci®c DNA binding of the p53 (Cho et al., 1994) . The mouse p53 codon 242 corresponds to the human p53 codon 245 which is commonly mutated in human tumorigenesis (reviewed in Hartmann et al., 1997). As illustrated in Figure 9 , the G-C transversion created a new HaeIII restriction site, allowing dierentiation between the wild-type and the mutated p53. Using the p53 speci®c primers #86 and P2 and the cDNA as template, the PCR generated the 192 bp DNA fragment as predicted. The new HaeIII restriction site was only demonstrable in the 8/61C PCR product (Figure 9c ). To test whether the 8/61C cells still contain one silent wild-type 53 gene, cellular DNA was extracted. With the genomic DNA of the three cell types as template, the PCR generated the 515 bp DNA fragment. HaeIII restriction enzyme treatment of the 8/61C PCR product exclusively generated the DNA fragment pattern speci®c for the p53 242 mutation (the intron 7 of p53 has additional HaeIII sites) but with the 8/61A and 8/61B 515 bp DNA segments only wild-type p53-speci®c DNA fragments were obtained (Figure 9c) . Therefore, either both p53 alleles are mutated or the second p53 allele was lost in the 8/61C cells, a question not further addressed in this investigation.
To investigate whether p53 242 still retains DNA binding speci®city, nuclear protein extracts were prepared from the 8/61C cells and gel shift experiments were performed. These experiments revealed that p53 242 still binds with a similar eciency as the wt protein to the p53 consensus sequence (Figure 10 ).
Since genes responsive to p53 transactivation include p21/WAF1 (El-Deiry et al., 1993), we tested whether transactivation occurs after doxorubicin or U.V. treatment. As exemplarily shown for doxorubicin treatment, the 8/61C cells accumulated p53 with the same eciency as the 8/61A and 8/61B cells but the p21 level was signi®cantly lower, indicating that the (Figure 8b) . Furthermore, the p53 242 renders the 8/61C cells highly resistant to doxorubicin treatment. About 24 h after addition of the anti-cancer drug to the culture medium only 5 ± 10% of the 8/61C cells were apoptotic while more than 90% of the 8/61A and the 8/61B cells did not survive doxorubicin treatment. Similarly, the T-antigen negative p537/7 cells (e.g. C-p537/7) were doxorubicin-insensitive, con®rming that it is the lack of functional p53 that mediates doxorubicin resistance.
To test whether the p53 missense mutation was a unique event limited to the 8/61 tumor, two additional tumors were isolated from the animals 8/ 60 and 8/62 and tissue culture cell lines were established. Immuno¯uorescence staining revealed that the tumor 8/60 contained only T-antigen positive cells and the ME-cells remained T-antigen positive in tissue culture even at a high passage number (4200). Therefore, these cells were not further considered in this investigation. In contrast, the tumor 8/62 and the corresponding tissue culture cells contained both T-antigen positive and T-antigen negative cells. RT ± PCR and DNA sequencing 4 cells were plated into soft agar (0.5% bottom layer, 0.33% top layer; SeaPlaque Agarose) and colony formation was analysed 2 weeks later (+++: more than 60% of the cells formed large clones as shown in Figure 4b experiments revealed that the T/t-antigen negative ME-tumor cells which grew again with a high eciency in soft agar and formed tumors in NMRI mice (e.g. 8/62C cells), had exactly the same missense mutation as the 8/61C cells (data not shown). Finally, we asked whether the p537/7 null state per se is sucient to maintain the transformed state in T/t-antigen negative ME-cells. Breast tumors were isolated from six WAP-SV-T/t.p537/7 animals and tissue culture cell lines were established. We observed that shortly after plating (passage 1 ± 2) the majority of the ME-cells stopped synthesizing the SV40 T/tantigen. T-antigen negative cell lines were established and anchorage-independent growth was assayed. In these experiments ME-cells from ®ve isolates (e.g. Cp537/7) grew with a high eciency in soft agar and ME-cells from one isolate formed only small colonies (data not shown).
This indicates that it is the loss and not the gain of p53 function that is responsible for maintaining the transformed state of the T/t-antigen negative cells.
Discussion
SV40 T/t-antigen and ME cell apoptosis
Control of apoptosis in mammalian cells is a complex process frequently in¯uenced by viral gene products (reviewed in Shen and Shenk, 1995) . By studying breast cancer formation in WAP-SV-T/t transgenic animals, we observed that the SV40 T/t-antigen induces extensive ME-cell death in late pregnancy. T-antigen which normally prevents cell death via inactivation of the p53-mediated pathway instead induces apoptosis around day 18 of pregnancy, eliminating the majority of the ME-cells from the mammary glands. Premature mammary gland involution also occurs in WAP-SV-T/ t.p537/7 double transgenic animals, indicating that the SV40 T-antigen induced apoptosis is p53-independent. Despite this dramatic ME-cell death rate, the mammary glands still contained multiple islands of Tantigen positive ME-cells after the lactation period. With time these cells expanded; as a further consequence of SV40 T/t-antigen synthesis, all animals developed breast tumors after the ®rst lactation period. In these cells, SV40 T/t-antigen did not exert an anti-apoptotic function since DNA fragmentation, which is a hallmark of apoptosis, was demonstrable in mammary gland segments isolated after pregnancy and in all tumor isolates. Therefore, extensive spontaneous apoptosis does not necessarily exclude breast cancer formation. Instead SV40 T-antigen, which is a strong mitogen (Graessmann and Graessmann, 1976) , induces ME-cell proliferation to a level which counterbalances the rate of ME-cell death. Bromodeoxyuridine incorporation experiments support this assumption (data not shown). Furthermore, the apoptotic pathway remains permanently activated in T/t-antigen positive ME-cells of established cell lines, generated either from mammary gland segments (late pregnancy, during lactation) or from breast tumors (e.g. 8/61A). This means that cell-cell communication and cellmatrix interactions, known to be essential for mammary gland dierentiation, regulation of milk protein synthesis and gland involution (Daniel and Silberstein, 1987) are not required for T/t-antigendependent ME-cell apoptosis. Consistent with the idea that it is solely SV40 T/t-antigen synthesis that causes ME-cell death is our observation that SV40 T/t-antigen negative ME-cells are not apoptotic (e.g. 8/61B). Furthermore, spontaneous apoptosis is induced again in these cells when SV40 T/t-antigen synthesis is reestablished (e.g. 8/61B-T/t). With regard to the involvement of small t-antigen and large T-antigen in inducing apoptosis, our preliminary results indicate that the high apoptotic rate is a synergistic eect of small t-and large SV40 T-antigen. The evidence for this is that the ME-cells from WAP-SV-T transgenic animals which synthesize only the large SV40 T-antigen are less apoptotic than cells from the WAP-SV-T/t animals (Graessmann et al., in preparation) .
It is not clear under what circumstances T-antigen induces or prevents cell death. As shown recently, the N-terminal domain of the T-antigen causes apoptosis in ®broblasts and epithelial cells while the carboxyl ± half of the T-antigen, which contains the pRb and p53 binding regions, has an anti-apoptotic function. Further, a p53-independent anti-apoptotic domain of the T-antigen has been identi®ed which has a high homology with the anti-apoptotic Ad5 E1B domain and with the BH1 region of the Bcl-2 protein family (Conzen et al., 1997) . Apparently, these anti-apoptotic T-antigen functions are not dominant in ME-cells and cannot neutralize the apoptotic activity of the T/tantigen.
Furthermore, spontaneous apoptosis of the T/tantigen positive ME-cells does not correlate with a change in the expression level of the major known apoptotic (e.g. Bax) or anti-apoptotic genes (e.g. Bcl-2) and there is no indication that the p53-independent cmyc pathway (Sakamuro et al., 1995; Hermeking et al., 1995; Friedlander et al., 1996) is central for ME-cell apoptosis (Figure 7) . Although an elevated protein kinase A (PKA) activity and higher AP-1 levels (Marti et al., 1994) , as well as a transition from anti-apoptotic Bcl-xL to the apoptotic Bcl-xS alternative splice form were observed one day after lactation (Heermeier et al., 1996) , no signi®cant dierence was demonstrable in this regard between the T/t antigen positive and negative ME-cells. Therefore, it remains unclear which cellular genes or gene products are the T/t-antigen target(s) that mediate the p53-independent ME-cell death, a pathway which still can be activated in the 8/ 61A and 8/61B cells by either doxorubicin or U.V. treatment.
SV40 T/t-antigen eciently immortalizes ME-cells in a hit and run manner
Under standard culture conditions (DMEM, 10% FCS) ME-cells from normal animals have a very limited life span, while stable ME-cell lines can be established with a high eciency from the WAP-SV-T/ t and WAP-SV-T/t.p537/7 transgenic animals. In contrast to apoptosis, ME-cell immortalization requires T/t-antigen synthesis only in the initial phase but not for maintenance since the cells that switch o both WAP and WAP-SV-T/t gene expression are eciently immortalized. It is generally assumed that inactivation of p53 function(s) is a prerequisite for immortalization, at least during the early phase (Bryan and Reddel, 1994; Namba et al., 1996) . However, our preliminary experiments, with transgenic animals which express only truncated T-antigen molecules in the ME-cells indicate that sequestration of p53 is not essential for immortalization of ME cells (data not shown). Therefore, it remains to be established which of the multiple SV40 T-antigen functions is responsible for ME-cell immortalization.
SV40 T/t-antigen selects for p53 mutations in ME-cells
Inactivation of the p53 tumor suppressor protein by missense mutation is frequently associated with breast cancer (Davido et al., 1991; Ozbun and Butel, 1995) . Although mice lacking p53 are susceptible to spontaneous tumor formation (Donehower et al., 1992) we did not observe spontaneous breast cancer formation in the p537/7 animals. In T/t-antigen expressing p537/7 animals, the p537/7 null state did not accelerate breast cancer formation. That inactivation of the p53 by SV40 T-antigen is not sucient to cause breast tumor formation is further indicated by our observation that transgenic animals which synthesize only the wild-type SV40 T-antigen (WAP-SV-T) develop breast tumors at a signi®cantly lower rate than the WAP-SV-T/t animals (Graessmann et al., in preparation) . We isolated various SV40 T/t-antigen negative cell lines from the WAP-SV-T/t breast tumors which still exhibit all the characteristics of maximally transformed cells including tumor formation in NMRI mice. DNA sequencing revealed that these cells carry a missense mutation at the second base of the p53 codon 242 (GGC-GCC; glycine to alanine), which is part of the core domain for the sequence-speci®c DNA binding. This codon corresponds to the human p53 codon 245, which is one of six mutation hotspots, and it is the only non-arginine residue frequently mutated in human tumors (reviewed in Ozbun and Butel, 1995) . This mutation did not aect DNA binding but signi®cantly reduce the transactivation function of p53. However, these ME-cells are very resistant to compounds frequently used for tumor-therapy (Table 1) .
Since this mutation was found in two out of three independent breast tumors analysed, occurrence of this mutation is not random. This is dierent from other transgenic models where p53 mutations were not selected for in SV40 T-antigen induced tumors (Moore et al., 1992; Shibata et al., 1996) . The fact that none of the NMRI animals ever developed a spontaneous breast tumor indicates that this mutation either did not occur in the non-transgenic animals or that this mutation itself is not sucient to cause tumor formation. Transgenic animals which carry the p53 242 mutation will hopefully answer this question in the future.
Although p53 is a very extensively analysed protein its precise role in cell transformation and apoptosis is not entirely clear. Recently, we have shown that p53, in both wild-type and mutant conformation, interacts with the transcriptional co-activator p300 and that complexes of p300 with wild-type p53 act to mediate cell-cycle arrest and apoptosis in response to induction of growth arrest by means of ionizing radiation and anti-cancer compounds (Avantaggiati et al., 1997) . At the molecular level, p300 is likely to have a coactivation function for certain promoters which are modulated in a p53-dependent manner. However, p53 also appears to inhibit the activity of p300 on selected genes, such as those regulated by the transcription factor AP1. Therefore, it is conceivable that coordinated silencing and activation of selected genes by p300 ± p53 complexes plays a crucial role in controlling cell growth and apoptosis. Moreover, increasing evidence has implicated members of the p300/CBP family in the development of the transformed phenotype either in human tumors (Borrow et al., 1996; Muraoka et al., 1996) , or in established cell lines expressing the SV40 T/t antigen (Avantaggiati et al., 1996) . This indicates that p300 is directly or indirectly involved in malignant cell transformation. Further studies will address the question of whether the activity of p300 is targeted by mutant forms of p53, in particular p53 242 .
Materials and methods
Histology and immuno¯uorescence staining
Tissue segments were ®xed in 10% formaldehyde in phosphate-buered saline (PBS), and embedded in paraf®n. Thin sections (4.5 mm) were stained with hematoxylin and eosin. Frozen sections were ®xed in 3% formaldehyde in PBS and stained for SV40 T-antigen, as described elsewhere (Graessmann and Graessmann, 1976) .
ME-cell lines
To establish ME-cell lines small tissue segments were isolated from mammary glands and from breast tumors, transferred into tissue culture dishes and cultivated in Dulbecco's modi®ed Eagle medium (DMEM), supplemented with 10% fetal calf serum. The pSV-neo DNA (Southern and Berg, 1982) was used to selected neomycin-resistant cell clones.
The TUNEL (TdT-mediated dUTP nick end labeling) stainings were done according to the manufacturer's instructions using the in situ cell death detection kit (Boehringer Mannheim). For propidium iodide staining the cells were incubated with 2 mg/ml propidium iodide for 15 min and the apoptotic cells were detected with ā uorescence microscope.
RNA preparation and Northern blot analysis
RNA was isolated from dierent tissues with guanidinium thiocyanate and puri®ed by pelleting through a 5.7 M cesium chloride cushion. For Northern blot analysis, 20 mg of total RNA were electrophoresed under denaturing conditions (1% agarose, Sigma; 0.33 M formaldehyde, Merck), transferred to a nylon membrane (Hybond-N, Amershan) and hybridized with 32 P-labeled SV40 BglI/ BamHI DNA fragment as described previously (Tzeng et al., 1993) . For the detection of p53 expression, the
